Active substance
Influenza vaccine
- SFDA 2
- WHO EML 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| AGRIPPAL S1 45MG\0.5ML PRE-FILLED SYRING | 45 mg | Suspension for injection in pre-filled syringe · Subcutaneous use | 1 Pre-filled syringe | SAR 23.60 | Biological · Prescription | NOVARTIS VACCINE AND DIAGNOSTICS S.R.I | Withdrawn by MAH · Not Marketed |
| FLUARIX 15McgOF ECH INFUENZA STR.5MLSRYG | 0.5 ml | Solution for injection · Subcutaneous use | 1 Pre-filled syringe | SAR 28.05 | Biological · Prescription | GLAXOSMITHKLINE (GSK) | Withdrawn by MAH · Not Marketed |
WHO WHO Model List of Essential Medicines (2025)
- 19.3. Immunologicals > Vaccines · core
Need for immunization against influenza
All vaccines should comply with the WHO requirements for biological substances.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.